Journal of the American Geriatrics Society最新文献

{"title":"Correction to “Attitudes on Participation in Clinical Drug Trials: A Nationally Representative Survey of Older Adults With Multimorbidity”","authors":"","doi":"10.1111/jgs.19233","DOIUrl":"10.1111/jgs.19233","url":null,"abstract":"<p>Schwartz JB, Liu R, Boscardin J, et al. Attitudes on participation in clinical drug trials: A nationally representative survey of older adults with multimorbidity. <i>J Am Geriatr Soc</i>. 2024;72(6):1717–1727. doi: 10.1111/jgs.18857</p><p>The authors have discovered an error in Table 2. In the highlighted row below, total <i>n</i> (%) is incorrect and should be: 632 (47.9%).</p><p><span>Afraid of side effects  632 (47.9)</span>  346 (52.8)  286 (43.1)</p><p>We apologize for this error.</p>","PeriodicalId":17240,"journal":{"name":"Journal of the American Geriatrics Society","volume":"72 12","pages":"3950"},"PeriodicalIF":4.3,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.19233","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Introduction for the 2024 Chinese Congress on Gerontology and Health Industry (CCGI) Abstracts","authors":"Sean X. Leng MD, PhD,&nbsp;Xiao-Ying Li MD","doi":"10.1111/jgs.19221","DOIUrl":"10.1111/jgs.19221","url":null,"abstract":"&lt;p&gt;It is once again with great pleasure that we introduce the research work to be presented at the 2024 Chinese Congress on Gerontology and Health Industry (CCGI), which is published in abstract form in this issue of the Journal of the American Geriatrics Society (JAGS). The 2024 CCGI conference is the continuation of the annual national geriatrics and gerontology conference co-organized and co-sponsored by a number of major Chinese professional healthcare organizations including the Chinese Medical Association (CMA) Geriatrics Branch and China Health Promotion Foundation. This year's CCGI conference will be held on November 1–3. 2024 in the city of Haikou, China's island province Hainan. We have 115 quality abstracts to be included in this issue.&lt;/p&gt;&lt;p&gt;While COVID-19 pandemic is largely behind us, its impact on world economy and scientific conferences continues to be palpable. The current economic downturn and overseas regional conflicts create additional challenges. Despite these difficulties, the 2024 CCGI conference will be held in person and the research work to be presented at the conference is as robust as that presented at previous years' CCGI conferences. Similar to the previous 11 years, the work to be presented at this year's CCGI conference encompasses many important areas of geriatrics and gerontology, from basic aging research to geriatric syndromes; from clinical observation and large epidemiological studies to clinical trials; and from biological investigations to social and behavioral research. Unique to this year, it emphasizes palliative care, cardiovascular aging and diseases, systems approach for senior health, as well as socioeconomic determinants of aging care. It also includes a broad range of studies of basic and translational aging research, such as investigation into chronic cytomegalovirus (CMV) infection as a potential contributing factor to immunosenescence and age-related chronic inflammation, longitudinal cohort studies, mechanistic studies in animal models, and other types of studies including clinical trials for the prevention and treatment of common geriatric syndromes and age-related diseases. Moreover, almost 20% of the abstracts are submitted by researchers from other countries and regions including the United States, European countries (Germany, UK), South Korea, Macao, etc., demonstrating a robust international representation. The work described here will be presented in the form of oral presentation or poster at the conference. The conference will have similar number of symposia with individual symposium on translational aging research, common geriatric syndromes, prevention, rehabilitation, nutrition, geriatric nursing, traditional Chinese medicine, community geriatrics care, and long-term care, and so on. Publication of such exemplary work in geriatrics and gerontology in this supplement issue of JAGS will further enhance scientific and scholarly exchanges between colleagues in China and geriatrics and g","PeriodicalId":17240,"journal":{"name":"Journal of the American Geriatrics Society","volume":"72 S4","pages":"S3-S5"},"PeriodicalIF":4.3,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.19221","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Abstracts for JGS Chinese Supplement","authors":"","doi":"10.1111/jgs.19222","DOIUrl":"10.1111/jgs.19222","url":null,"abstract":"","PeriodicalId":17240,"journal":{"name":"Journal of the American Geriatrics Society","volume":"72 S4","pages":"S6-S68"},"PeriodicalIF":4.3,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.19222","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reply to: Comment on: Measuring frailty in clinical practice: Overcoming challenges with implementation","authors":"Tamara Damjanac MD,&nbsp;David H. Lynch MD","doi":"10.1111/jgs.19235","DOIUrl":"10.1111/jgs.19235","url":null,"abstract":"&lt;p&gt;We thank Dr. Van Grootven for his interest in our article about measuring frailty in clinical practice.&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt; We appreciated the engagement with the article as well as the constructive feedback. The discussion about frailty assessments and their utility in clinical practice is an important one. Dr. Van Grootven brings up several points that advance this discussion and will help inform future projects within the field.&lt;/p&gt;&lt;p&gt;We acknowledge the limitations of this work highlighted, namely the need for calibration of the predictions and classification statistics to understand misclassification as well as comparisons with the current standard of care (a geriatrician's clinical judgment).&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt; These are excellent suggestions for future directions. Although these would expand the discussion and provide additional important information, they are also beyond the scope of this quality improvement project.&lt;/p&gt;&lt;p&gt;The study aimed to examine whether the predictive ability of frailty measures in routine practice was comparable to that in controlled research settings. Although it is useful to judge clinical utility in the context of outcomes, within the framework of this study, the term “utility” refers specifically to the measures' predictive consistency with findings from larger, standardized cohort studies, not to the immediate clinical impact on patient outcomes.&lt;/p&gt;&lt;p&gt;We appreciate your discussion of important next steps. This has provided an opportunity to consider future directions within the field. Although there are several studies that show frailty's predictive capacity,&lt;span&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt; we agree that there is a need for larger-scale effectiveness studies to assess whether implementing frailty assessments in routine practice leads to improved patient outcomes. This would be crucial for determining the clinical utility of frailty measures in practice. We hope to have the opportunity to work on such a project in the future.&lt;/p&gt;&lt;p&gt;Our study showed that frailty assessments can be integrated into standard clinical practice and have predictive consistency. We hope that additional work can be done showing that frailty assessments can help improve outcomes. Further development of real-world evidence of frailty prevention, reversal, and management is crucial to advancing the field.&lt;/p&gt;&lt;p&gt;All listed authors had full access to all the data in the study, take responsibility for the integrity of the data and the accuracy of the data analysis, and had authority over manuscript preparation, the decision to submit the manuscript for publication, and approved its current contents. All authors meet the criteria for authorship stated in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.&lt;/p&gt;&lt;p&gt;No personal or financial conflicts of interest.&lt;/p&gt;&lt;p&gt;Research reported in this publication was supported in part by the Duke Endowment and the University of North Carolina at Chapel Hill's Center for Aging a","PeriodicalId":17240,"journal":{"name":"Journal of the American Geriatrics Society","volume":"73 3","pages":"977-978"},"PeriodicalIF":4.3,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.19235","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Vaccinations in older adults: Optimization, strategies, and latest guidelines","authors":"Aileen R. Pangilinan MD,&nbsp;Sharon A. Brangman MD,&nbsp;Stefan Gravenstein MD MPH,&nbsp;Kenneth Schmader MD,&nbsp;George A. Kuchel MD","doi":"10.1111/jgs.19243","DOIUrl":"10.1111/jgs.19243","url":null,"abstract":"<p>This article is a summary of the first AGS Symposium entitled “<i>Update on Vaccination Strategies for Older Adults</i>: <i>Matching the Approach to the Individual and the Care Setting</i>.” Given declines in host defenses and immune function with aging, vaccinations play a pivotal role in fortifying older adults against preventable infections, resulting diseases, disability, and death. Current guidelines generally list recommendations applicable for an average older adult of a given chronological age. However, growing evidence indicates that heterogeneity in terms of factors as varied as biological sex, frailty, functional status, and multimorbidity may impact vaccine responses and clinical outcomes. As a result, clinicians will increasingly need to take these additional factors into consideration as they seek to improve outcomes through improved targeting of such aging-related heterogeneity. Moreover, efforts at protecting older citizens through vaccination must also include strategies to overcome barriers to the adoption of vaccine recommendations in varied settings including long-term care. This 2023 AGS Plenary Symposium sought to commence a broader dialogue across AGS and beyond on optimizing vaccinations for older adults, ensuring not only extended lifespans but also healthier and more active lives. This report is not a systematic review, and thus should not be considered comprehensive.</p>","PeriodicalId":17240,"journal":{"name":"Journal of the American Geriatrics Society","volume":"73 1","pages":"20-28"},"PeriodicalIF":4.3,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comment on: Measuring frailty in clinical practice: Overcoming challenges with implementation","authors":"Bastiaan Van Grootven PhD","doi":"10.1111/jgs.19234","DOIUrl":"10.1111/jgs.19234","url":null,"abstract":"<p>I read with interest the article of Damjanac et al. on measuring frailty in clinical practice. The authors implemented the two major frailty measurements, the physical frailty phenotype and the accumulated deficits model, to investigate their ‘utility’ for outpatient clinic visits.<span>¹</span> Frailty was a significant predictor for hospitalization and death, and the predictive performance was roughly equal between the phenotype and deficits model (the concordance c-index ranged between 0.7 and 0.73). The authors concluded that the measurement could be implemented in practice to identify patients at risk for adverse clinical outcomes, as the tools ‘proved predictive of patient-centered outcomes’.</p><p>Although the finding that it is feasible to integrate frailty assessment in clinical practice is important, the results do not support the clinical utility of frailty assessments in practice, in my opinion. The discrimination statistic that was used only tells us that a frailty score can distinguish between patients with and without the outcome of interest (on average). In practice, we are interested in how correct a prediction is for individuals, and what happens with the individual when a prediction is made (i.e. benefits, costs, and harms).<span>²</span> I would encourage the authors to further explore this by investigating the calibration of the predictions, coupled with classification statistics, to understand misclassification. Furthermore, for predictions to be clinical useful, they should be better than the current standard of care, which would include clinical judgment of risk based on a comprehensive geriatric assessment; that is, does a frailty score predict better than the clinical judgment of a geriatrician. Unfortunately, this information is absent.</p><p>Ultimately, the clinical utility of any frailty measurement in practice can only be judged when it also improves outcomes (e.g. in an evaluation study where the frailty measurement is introduced and compared against a control group). In this change model, it is hypothesized that adding a frailty assessment results in an improved care plan leading to improved patient outcomes, that without the assessment would not be the case. I am not optimistic that we are close to this scenario. Although frailty has been consistently prevented or reversed in controlled clinical trials,<span>³</span> I have not seen convincing evidence that this has been translated and implemented beyond the trial world in clinical practice. I look forward to the much-needed development of real-world evidence concerning frailty prevention, reversal, and management.</p><p>None.</p><p>The authors have no conflicts of interest.</p><p>None.</p>","PeriodicalId":17240,"journal":{"name":"Journal of the American Geriatrics Society","volume":"73 3","pages":"976"},"PeriodicalIF":4.3,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.19234","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mortality after hip fracture among Black and White women: Findings from a northern California integrated healthcare system","authors":"Joan C. Lo MD,&nbsp;Malini Chandra MS MBA,&nbsp;Uzoezi Ozomaro MD PhD,&nbsp;Wei Yang MD,&nbsp;Morali Sharma MD,&nbsp;Amber L. Wheeler MD,&nbsp;Jeanne A. Darbinian MPH,&nbsp;Catherine Lee PhD","doi":"10.1111/jgs.19217","DOIUrl":"10.1111/jgs.19217","url":null,"abstract":"","PeriodicalId":17240,"journal":{"name":"Journal of the American Geriatrics Society","volume":"73 2","pages":"632-635"},"PeriodicalIF":4.3,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Whether and how to store firearms in the home: Qualitative insights from care partner experiences in the Safety in Dementia Trial","authors":"Christopher E. Knoepke PhD, MSW,&nbsp;Kayla Meza MPH,&nbsp;Jennifer D. Portz PhD, MSW,&nbsp;Megan L. Ranney MD, MPH,&nbsp;Stacy M. Fisher MD,&nbsp;Faris Omeragic BS,&nbsp;Emily Greenway MPH,&nbsp;Mirella Castaneda BS,&nbsp;Daniel D. Matlock MD, MPH,&nbsp;Marian E. Betz MD, MPH","doi":"10.1111/jgs.19242","DOIUrl":"10.1111/jgs.19242","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Most people with dementia (PWD) in the United States live in community settings supported by family and/or unpaid care partners. Firearms access is one of many decisions care partners navigate alongside PWD in efforts to prevent injuries and deaths. Conversations about firearms access are socially challenging, although specific challenges to be overcome have not been described.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>As part of the larger Safety in Dementia Trial, we interviewed care partners about their views and experiences regarding firearms access in the home where the PWD resides. Interviewees were English-speaking adults (≥18 years) in the United States who are unpaid care partners of community-dwelling PWD. Responses to interview discussions related to (1) a desire for safety, and (2) fear of firearm violence was analyzed using a focusing process to categorize views into essential themes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Fifty care partners, who were primarily female (58%), White (66%), adult children (56%), and living in the same household (64%), participated in interviews between February 2023–February 2024. Dominant themes emerging from the focusing technique included (1) firearms as a necessary component of home safety; (2) fear of accidental/impulsive firearm violence; (3) observed risk and “near misses”; and (4) differing views on home firearms as a source of conflict. Thematic descriptions did not differ according to care partner's relationship to the PWD (adult child, spouse, other).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Considering whether and how to alter access to firearms where PWD reside can be difficult for care partners to navigate. Care partners expressed a desire to limit firearms access, but worried both about creating conflict with the PWD and the self-defense implications of making firearms inaccessible. Findings were similar across subsets of care partners indicating that standardized tools and messaging to care partners may be effective in promoting safety in homes with PWD.</p>\u0000 </section>\u0000 </div>","PeriodicalId":17240,"journal":{"name":"Journal of the American Geriatrics Society","volume":"73 2","pages":"379-388"},"PeriodicalIF":4.3,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.19242","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessing causality in deprescribing studies: A focus on adverse drug events and adverse drug withdrawal events","authors":"Xiaojuan Li PhD,&nbsp;Elizabeth A. Bayliss MD, MSPH,&nbsp;M. Alan Brookhart PhD,&nbsp;Matthew L. Maciejewski PhD","doi":"10.1111/jgs.19241","DOIUrl":"10.1111/jgs.19241","url":null,"abstract":"<p>Generating real-world evidence about the effect of medication discontinuation or dose reduction on outcomes, such as reduction of adverse drug effects (ADE; intended benefit) and occurrence of adverse drug withdrawal events (ADWE; unintended harm), is crucial to informing deprescribing decisions. Determining the causal effects of deprescribing is difficult for many reasons, including lack of randomization in real-world study designs and other design and measurement issues that pose threats to internal validity. The inherent challenge is how to identify the effects, both intended benefits and unintended harms, of a new medication stoppage or reduction when implemented in patients with many potential clinical and social risks that may influence the likelihood of deprescribing as well as outcomes. We discuss methodological issues of estimating the effect of medication discontinuation or reduction on risk of ADEs and ADWEs considering: (1) sampling study populations of sufficient size with the potential to demonstrate clinically meaningful and quantifiable outcomes, (2) accurate and appropriately timed measurement of covariates, outcomes, and discontinuation, and (3) statistical approaches to managing confounding and other biases inherent in long-term medication use by individuals with multiple morbidities. Designing rigorous deprescribing studies that address internal validity threats will support evidence generation by improving the ability to assess benefits and harms when the exposure of interest is the <i>absence</i> of a medication. Iterative learnings about data quality, variable definition, variable measurement, and exposure-outcome associations will inform strategies to improve the causal inferences possible in real-world deprescribing studies.</p>","PeriodicalId":17240,"journal":{"name":"Journal of the American Geriatrics Society","volume":"73 3","pages":"697-706"},"PeriodicalIF":4.3,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prognostic understanding among caregivers of persons with dementia: A scoping review","authors":"Ishwarya Balasubramanian PhD,&nbsp;Ellie Bostwick Andres DrPH,&nbsp;Louisa Camille Poco PhD,&nbsp;Chetna Malhotra MD","doi":"10.1111/jgs.19245","DOIUrl":"10.1111/jgs.19245","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Despite the influence of caregivers' prognostic understanding (PU) on the end-of-life care for persons with dementia (PwDs), the literature on PU of caregivers of PwDs is sparse. We conducted a scoping review to understand the variation in existing definitions and measurement of caregivers' PU for PwDs. We also aimed to synthesize the prevalence of caregivers' correct PU and the factors (caregiver, PwD and healthcare related) associated with it.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We systematically searched four databases—MEDLINE/PubMed, EMBASE, SCOPUS, and CINAHL. We included studies where study participants were informal caregivers, their PU was assessed, and measurement tool was implicitly described. We excluded studies where study participants were paid caregivers.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Out of the 2160 studies screened, we included 15 published between 2009 and 2023. The included studies measured caregivers' PU as limited estimated life expectancy, understanding that dementia is incurable and life-limiting. Estimated life expectancy was the most common measure of PU among caregivers to PwDs. Across studies, around 90% of caregivers acknowledged dementia as incurable, while only about 40% acknowledged it as life-limiting. Caregivers of PwDs who were sicker (acute medical problems or functional dependence) and those who had discussed goals of care with healthcare providers were more likely to have more accurate PU for PwDs. Caregivers' with better PU were more likely to state a preference for comfort-focused care, and their PwDs were likely to receive fewer burdensome interventions and experience greater comfort during the dying process.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Our findings highlight the need for a comprehensive measure to assess the multifaceted nature of caregivers' PU, delve deeper into factors influencing caregivers' PU, and explore its impact on caregivers themselves.</p>\u0000 </section>\u0000 </div>","PeriodicalId":17240,"journal":{"name":"Journal of the American Geriatrics Society","volume":"73 3","pages":"947-955"},"PeriodicalIF":4.3,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}